Zydus Healthcare receives approval from the CDSCO Panel to investigate Vilanterol FDC, Glycopyrronium, and Fluticasone Furoate.

Published Date: 23 Oct 2023

New Delhi: Drug giant Zydus has been given approval by the Subject Expert Committee (SEC), which is housed under the Central Drug Standard Control Organization (CDSCO).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Relationship-building key to addressing oncologist shortages in rural care

2.

New protein target discovered for childhood medulloblastomas

3.

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

4.

Papillary thyroid cancer: New markers offer hope for tailored treatment

5.

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot